Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)
CUSIP: 69012T305
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 67,246,397
- Total 13F shares
- 5,938,598
- Share change
- -1,145,431
- Total reported value
- $9,501,555
- Price per share
- $1.60
- Number of holders
- 63
- Value change
- -$1,298,121
- Number of buys
- 34
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69012T305:
Top shareholders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GMS Ventures & Investments |
13D/G
|
— |
50%
|
29,040,929
|
$45,303,849 | +$20,057,142 | 27 May 2025 | |
| Arun Kumar Pillai |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
22,982,529
|
$26,085,170 | — | 01 Feb 2022 | |
| Tenshi Healthcare Pte. Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,982,529
|
$26,085,170 | — | 21 Apr 2022 | |
| Sukhtian Ghiath M. |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
22,123,787
mixed-class rows
|
$18,973,302 | — | 27 May 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
|
— |
5%
|
2,220,000
|
$4,484,400 | $0 | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
3.4%
|
1,500,000
|
$3,030,000 | -$808,000 | 30 Jun 2025 | |
| TANG CAPITAL PARTNERS LP |
13D/G
|
TANG CAPITAL MANAGEMENT, LLC |
6.4%
|
1,682,502
|
$2,624,703 | $0 | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
2.3%
|
1,552,744
|
$1,894,346 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.8%
|
1,242,372
|
$1,515,695 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.3%
|
857,142
|
$1,045,713 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
837,407
|
$1,021,637 | — | 31 Mar 2025 | |
| Terry Dagnon |
3/4/5
|
Chief Operations Officer |
—
mixed-class rows
|
845,201
mixed-class rows
|
$741,221 | — | 20 Apr 2023 | |
| Syntone Ventures LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,776,867
mixed-class rows
|
$716,284 | — | 15 Apr 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
433,853
|
$529,397 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0.54%
|
366,201
|
$446,765 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
288,260
|
$351,677 | — | 31 Mar 2025 | |
| Jeff Evanson |
3/4/5
|
CHIEF COMMERCIAL OFFICER |
—
mixed-class rows
|
833,459
mixed-class rows
|
$339,553 | — | 20 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.26%
|
175,237
|
$213,789 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
126,955
|
$154,885 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
103,524
|
$126,299 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
94,603
|
$115,416 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
84,671
|
$103,299 | — | 31 Mar 2025 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.11%
|
74,039
|
$90,328 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
70,922
|
$86,525 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
39,474
|
$48,158 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
36,060
|
$43,993 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
28,151
|
$34,000 | — | 31 Mar 2025 | |
| Lawrence A. Kenyon |
3/4/5
|
Chief Financial Officer, Director |
—
mixed-class rows
|
18,446
mixed-class rows
|
$33,828 | — | 26 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
27,324
|
$33,335 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
20,719
|
$25,277 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
17,760
|
$21,668 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
17,040
|
$20,789 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
16,170
|
$19,719 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
15,127
|
$18,455 | — | 31 Mar 2025 | |
| Christensen, King & Associates Investment Services, Inc. |
13F
|
Company |
0.02%
|
11,910
|
$16,674 | — | 31 Mar 2025 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.02%
|
13,500
|
$16,470 | — | 31 Mar 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.02%
|
11,296
|
$13,781 | — | 31 Mar 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
10,726
|
$13,085 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
10,663
|
$13,009 | — | 31 Mar 2025 | |
| Fifth Third Wealth Advisors LLC |
13F
|
Company |
0.01%
|
10,000
|
$12,200 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
9,990
|
$12,188 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
9,981
|
$12,177 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
9,056
|
$11,048 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
8,658
|
$10,563 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
8,403
|
$10,251 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
7,978
|
$9,733 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0.01%
|
6,854
|
$8,000 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
6,229
|
$7,599 | — | 31 Mar 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
2,536
|
$3,094 | — | 31 Mar 2025 | |
| Riggs Asset Managment Co. Inc. |
13F
|
Company |
0%
|
2,500
|
$3,050 | — | 31 Mar 2025 |
Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q2 2025
As of 30 Jun 2025,
Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,938,598 shares.
The largest 10 holders included
Schonfeld Strategic Advisors LLC, VANGUARD GROUP INC, MORGAN STANLEY, Steward Partners Investment Advisory, LLC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Squarepoint Ops LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
61
Q2 2025 holders
63
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.